Published in TB and Outbreaks Week, February 2nd, 2010
"In this multicentre, double-blind, randomised trial, 12 691 people aged 3 years or older were recruited in ten centres in China. in each Centre, participants were stratified by age and randomly assigned by a random number table to receive one of several vaccine formulations or placebo. The study assessed eight formulations: split-virion formulation containing 7.5 mu g, 15 mu g, or 30 mu g...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.